{
“authorizedApplication.authorizedPartI.products.0”: [
{
“productName”: “Hydrocortisone”,
“description”: “Hydrocortisone is a medication that helps to replace or supplement the natural hormone cortisol in the body. It is often used in conditions where the body does not produce enough cortisol, such as in adrenal insufficiency. In this trial, it is used to study its effects on cardiometabolic risk factors and chronobiology patterns in patients with autonomous adrenal cortisol secretion.”
},
{
“productName”: “Metyrapone”,
“description”: “Metyrapone is a medication that reduces the production of cortisol in the body. It is used to help control excessive cortisol levels, which can be a problem in certain medical conditions. In this trial, it is used to understand how lowering cortisol levels affects cardiometabolic risk factors and chronobiology patterns in patients with autonomous adrenal cortisol secretion.”
}
]
}

Autonomous Cortisol Secretion – This condition occurs when the adrenal glands produce cortisol without the usual regulatory signals from the pituitary gland. It is often associated with adrenal adenomas, which are benign tumors of the adrenal gland. Over time, the excess cortisol can lead to changes in metabolism, affecting how the body processes fats, proteins, and carbohydrates. This can result in increased fat deposition, particularly in the abdominal area, and may alter insulin sensitivity. The condition can also impact cardiovascular health, potentially affecting heart function and blood pressure. Additionally, it may influence the body’s inflammatory response, leading to changes in systemic inflammation markers.